Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXA-10 in Obese Asthmatics
NCT03762395Phase 2Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Feb 2023
- Primary completion
- Nov 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing CXA-10 with Matching Placebo (2 arms). Primary endpoints: Change in Methacholine challenge dose per spirometry at 18 weeks and Changes in pre-bronchodilator FEV1 per spirometry at 18 weeks. Started Feb 2023; status: recruiting.
02
Drugs
10-nitro-oleic acid
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03762395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03762395.